(Q28292279)

3

0 references

author name string

Jeffrey C Dyason

2

0 references

Mark von Itzstein

4

0 references

Kevin M Downard

Analytical and Bioanalytical Chemistry

5

0 references

language of work or name

English

0 references

publication date

August 2013

0 references

published in

0 references

volume

405

0 references

page(s)

6563-72

0 references

issue

20

0 references

describes a project that uses

1 reference

https://scigraph.springernature.com/pub.10.1007/s00216-013-7068-x

0 references

cites work

Pandemic influenza: an inconvenient mutation.

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Analysis of inhibitor binding in influenza virus neuraminidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Rational design of potent sialidase-based inhibitors of influenza virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Discovery and development of GS 4104 (oseltamivir): an orally active influenza neuraminidase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

The neuraminidase of influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Anti-influenza drugs: the development of sialidase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Targeting pandemic influenza: a primer on influenza antivirals and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Permissive secondary mutations enable the evolution of influenza oseltamivir resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Oseltamivir resistance--disabling our influenza defenses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Global transmission of oseltamivir-resistant influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Structural and Functional Analysis of Laninamivir and its Octanoate Prodrug Reveals Group Specific Mechanisms for Influenza NA Inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

A secondary sialic acid binding site on influenza virus neuraminidase: fact or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Chalcones as novel influenza A (H1N1) neuraminidase inhibitors from Glycyrrhiza inflata

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Edible bird's nest extract inhibits influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Anti-influenza virus activities of flavonoids from the medicinal plant Elsholtzia rugulosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Anti-influenza virus activity of biflavonoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Inhibition of several strains of influenza virus in vitro and reduction of symptoms by an elderberry extract (Sambucus nigra L.) during an outbreak of influenza B Panama

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

In vivo anti-influenza virus activity of plant flavonoids possessing inhibitory activity for influenza virus sialidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Inhibition of influenza virus sialidase and anti-influenza virus activity by plant flavonoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Effects of flavonoids on immune and inflammatory cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Combining molecular docking and molecular dynamics to predict the binding modes of flavonoid derivatives with the neuraminidase of the 2009 H1N1 influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Inhibitory activity of a standardized elderberry liquid extract against clinically-relevant human respiratory bacterial pathogens and influenza A and B viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Direct identification of protein epitopes by mass spectrometry without immobilization of antibody and isolation of antibody-peptide complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Antigenic surveillance of the influenza virus by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

A proteomics approach to survey the antigenicity of the influenza virus by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Antigenic characterisation of H3N2 subtypes of the influenza virus by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Antigenicity of a type A influenza virus through comparison of hemagglutination inhibition and mass spectrometry immunoassays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Anti-viral inhibitor binding to influenza neuraminidase by MALDI mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

FindPept, a tool to identify unmatched masses in peptide mass fingerprinting protein identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

A computer algorithm for the identification of protein interactions from the spectra of masses (PRISM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

The 2009 pandemic H1N1 neuraminidase N1 lacks the 150-cavity in its active site

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

AstexViewer: a visualisation aid for structure-based drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Influenza virus sialidase: effect of calcium on steady-state kinetic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X

Sensitivity of influenza viruses to zanamivir and oseltamivir: a study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7068-X